SYNLAB International is a leader in the Health Care sector, offering innovative and reliable medical diagnostics to patients, doctors, hospitals, governments, and corporates. Founded in 2010 and headquartered in Germany, SYNLAB operates in 30+ countries across four continents, employing more than 27,000 individuals, including over 2,000 medical experts. With a focus on medical diagnostic services and specialty testing, SYNLAB has established itself as a prominent player in the European market. Despite lacking specific details about the last investment and investors, the company's extensive reach and strong presence in the medical diagnostics industry make it an intriguing prospect for potential investors looking to capitalize on the growing demand for healthcare services in Europe and beyond.
There is no investment information
No recent news or press coverage available for SYNLAB International.
We care about your data, and we'd love to use cookies make your experience better.
